• Genome in a Bottle Consortium--Progress and Planning Workshop

    AGENCY: National Institute of Standards and Technology, Commerce.

    ACTION: Notice of public workshop.

    SUMMARY: The National Institute of Standards and Technology (NIST) announces the Genome in a Bottle Consortium--Progress and Planning Workshop to be held on Thursday, January 28, 2016, and Friday, January 29, 2016. The Genome in a Bottle Consortium is developing the reference materials, reference methods, and reference data needed to assess confidence in human whole genome variant calls. A principal motivation for this consortium is to enable performance assessment of sequencing and science-based regulatory oversight of clinical sequencing. The purpose of this workshop is to update participants about progress of the consortium work, continue to get broad input from individual stakeholders to update or refine the consortium work plan, continue to broadly solicit consortium membership from interested stakeholders, and invite members to participate in work plan implementation.

    Topics of discussion at this workshop will include progress and planning of the Analysis Group, which is analyzing and integrating the large variety of sequencing data for four candidate NIST Reference Materials (RMs), with a particular focus on challenging types of variants and challenging regions of the genome. Other potential NIST RMs that might be developed by the consortium will also be discussed.

    DATES: The Genome in a Bottle Consortium workshop will be held on Thursday, January 28, 2016 from 9:00 a.m. to 5:30 p.m. Pacific Time, and Friday, January 29, 2016 from 9:00 a.m. to 1:00 p.m. Pacific Time. Attendees must register by 5:00 p.m. Pacific Time on Thursday, January 21, 2016.

    ADDRESSES: The meeting will be held on the second floor of the Li Ka Shing Conference Center, Stanford University, 291 Campus Drive, Palo Alto, CA 94305. Please note admittance instructions under the SUPPLEMENTARY INFORMATION section of this notice.

    FOR FURTHER INFORMATION CONTACT: For further information contact Justin Zook by email at or by phone at (301) 975-4133 or Marc Salit by email at or by phone at (650) 350-2338. To register, go to:

  • Interagency Working Group on the Harmful Algal Bloom and Hypoxia Research and Control Amendments Act

    AGENCY: National Ocean Service, National Oceanic and Atmospheric Administration, U.S. Department of Commerce.

    ACTION: Notice, Webinars.

    SUMMARY: The National Ocean Service (NOS) of the National Oceanic and Atmospheric Administration (NOAA) publishes this notice to announce town hall-style webinars to promote discussion between federal representatives and stakeholders on topics related to harmful algal blooms (HABs) and hypoxia occurring in the Great Lakes region. These webinars are being conducted in accordance with the Harmful Algal Bloom and Hypoxia Research and Control Amendments Act of 2014 (HABHRCA), which directs federal agencies to advance the understanding of HAB and hypoxia events, and to respond to, detect, predict, control, and mitigate these events to the greatest extent possible.

    Through these webinars, the Interagency Working Group on HABHRCA (IWG-HABHRCA) seeks to engage a wide range of stakeholders in the Great lakes region, including scientists, resource managers, agricultural producers, commercial and recreational fishermen, other industry interests, international and non-profit organizations, and the interested public.

    DATES: See SUPPLEMENTARY INFORMATION section for meeting dates.

    ADDRESSES: See SUPPLEMENTARY INFORMATION section for meeting web addresses.

    FOR FURTHER INFORMATION CONTACT: Caitlin Gould (, 240-533-0290) or Stacey DeGrasse (, 240-402- 1470)

  • Mid-Atlantic Fishery Management Council (MAFMC); Public Meeting

    AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and Atmospheric Administration (NOAA), Commerce.

    ACTION: Notice; public meeting.

    SUMMARY: The Mid-Atlantic Fishery Management Council's (MAFMC) Ecosystem and Ocean Planning Committee will hold a public meeting.

    DATES: The meeting will be held on Friday, January 22, 2016, from 9:30 a.m. to 4:30 p.m. For agenda details, see SUPPLEMENTARY INFORMATION.

    ADDRESSES: The meeting will be held at the Double Tree by Hilton Baltimore-BWI Airport, 890 Elkridge Landing Road, Linthicum, Maryland, 21090; telephone: (410) 859-8400.

    Council address: Mid-Atlantic Fishery Management Council, 800 N. State Street, Suite 201, Dover, DE 19901; telephone: (302) 674-2331; Web site:

    FOR FURTHER INFORMATION CONTACT: Christopher M. Moore, Ph.D., Executive Director, Mid-Atlantic Fishery Management Council, telephone: (302) 526-5255.

  • Science Advisory Board

    AGENCY: Office of Oceanic and Atmospheric Research (OAR), National Oceanic and Atmospheric Administration (NOAA), Department of Commerce (DOC).

    ACTION: Notice of public meeting.

    SUMMARY: This notice sets forth the schedule and proposed agenda of a forthcoming meeting of the NOAA Science Advisory Board. The members will discuss and provide advice on issues outlined in the section on Matters to be considered.

    DATES: Time and Date: The meeting is scheduled for January 28, 2016 from 1:00 p.m. to 4:00 p.m. Eastern Standard Time.

    ADDRESSES: Conference call. Public access is available at: NOAA, SSMC 3, Room 11836, 1315 East-West Highway, Silver Spring, MD. Members of the public will not be able to dial in to this meeting.

    Status: The meeting will be open to public participation with a 5- minute public comment period from 3:50 p.m. Eastern Standard Time. The SAB expects that public statements presented at its meetings will not be repetitive of previously submitted verbal or written statements. In general, each individual or group making a verbal presentation will be limited to a total time of one minute. Written comments should be received in the SAB Executive Director's Office by January 21 to provide sufficient time for SAB review. Written comments received by the SAB Executive Director after January 21, will be distributed to the SAB, but may not be reviewed prior to the meeting date.

    Special Accommodations: These meetings are physically accessible to people with disabilities. Requests for special accommodations may be directed no later than 12 p.m. on January 21, to Dr. Elizabeth Turner, Acting SAB Executive Director, NOAA, Room 146 Gregg Hall, 35 Colovos Road, Durham, NH 03824; email:

    SUPPLEMENTARY INFORMATION: The NOAA Science Advisory Board (SAB) was established by a Decision Memorandum dated September 25, 1997, and is the only Federal Advisory Committee with responsibility to advise the Under Secretary of Commerce for Oceans and Atmosphere on strategies for research, education, and application of science to operations and information services. SAB activities and advice provide necessary input to ensure that National Oceanic and Atmospheric Administration (NOAA) science programs are of the highest quality and provide optimal support to resource management.

    Matters To Be Considered: The meeting will include the following topics: (1) Report from the Environmental Information Services Working Group on a Review of the NOAA Partnership Policy; (2) Discussion of Ways to Optimize SAB and Working Group Operations and Working Group staff support from the Line Offices and (3) Continued Discussion of Strategic Advice to NOAA and Impact on SAB Operations. For the latest agenda, please visit the SAB Web site at

    FOR FURTHER INFORMATION CONTACT: Dr. Elizabeth Turner Acting Executive Director, Science Advisory Board, NOAA, Room 146 Gregg Hall, 35 Colovos Road, Durham, NH 03824. Email:; or visit the NOAA SAB Web site at

  • Environmental Protection Agency

  • Notification of a Public Meeting of the Great Lakes Advisory Board

    AGENCY: Environmental Protection Agency (EPA).

    ACTION: Notice.

    SUMMARY: The Environmental Protection Agency (EPA) announces a public meeting of the Great Lakes Advisory Board (Board). The purpose of this meeting is to discuss the Great Lakes Restoration Initiative (GLRI) covering FY15-19 and other relevant matters.

    DATES: The meeting will be held on Wednesday, January 27, 2016 from 10 a.m. to 3 p.m. Central Time, 11 a.m. to 4 p.m. Eastern Time. An opportunity will be provided to the public to comment.

    ADDRESSES: The meeting will be held at 77 W. Jackson, 19th Floor, Chicago, Illinois. For those unable to attend in person, this meeting will also be available telephonically. The teleconference number is 877-226-9607 and the conference ID number is 4218582837.

    FOR FURTHER INFORMATION CONTACT: Any member of the public wishing further information regarding this meeting may contact Rita Cestaric, Designated Federal Officer (DFO), by email at General information on the GLRI and the Board can be found at

  • Health and Human Services

  • Meeting of the Presidential Advisory Council on HIV/AIDS

    AGENCY: Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health.

    ACTION: Notice.

    SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Service is hereby giving notice that the Presidential Advisory Council on HIV/AIDS (PACHA) will be holding a meeting to continue discussions and possibly develop recommendations regarding People Living with HIV/AIDS. PACHA members will have discussions regarding Health System Transformations, community approaches to implementing the Updated National HIV/AIDS Strategy, and food as medicine. The meeting will be open to the public.

    DATES: The meeting will be held on January 28, 2016, from 8:30 a.m. to approximately 5:00 p.m. (ET) and January 29, 2016, from 9:00 a.m. to approximately 12:30 p.m. (ET).

    ADDRESSES: 200 Independence Avenue SW., Washington, DC 20201.

    FOR FURTHER INFORMATION CONTACT: Ms. Caroline Talev, Public Health Analyst, Presidential Advisory Council on HIV/AIDS, Department of Health and Human Services, 200 Independence Avenue SW., Room 443H, Hubert H. Humphrey Building, Washington, DC 20201; (202) 205-1178. More detailed information about PACHA can be obtained by accessing the Council's Web site

  • Vaccines and Related Biological Products Advisory Committee; Notice of Meeting

    AGENCY: Food and Drug Administration, HHS.

    ACTION: Notice.

    This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public.

    Name of Committee: Vaccines and Related Biological Products Advisory Committee.

    General Function of the Committee: To provide advice and recommendations to the Agency on FDA's regulatory issues.

    Date and Time: The meeting will be held on March 4, 2016, from 8:30 a.m. to 3 p.m.

    Location: FDA White Oak Campus, 10903 New Hampshire Ave., Building 31 Conference Center, the Great Room (Rm. 1503), Silver Spring, MD 20993-0002. For those unable to attend in person, the meeting will also be Web cast and will be available at the following link Answers to commonly asked questions including information regarding special accommodations due to a disability, visitor parking, and transportation may be accessed at:

    Contact Person: Sujata Vijh or Denise Royster, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Rm. 6128, Silver Spring, MD 20993-0002, 240- 402-7107 or 240-402-8158, email: or or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). A notice in the Federal Register about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the Agency's Web site at and scroll down to the appropriate advisory committee meeting link, or call the advisory committee information line to learn about possible modifications before coming to the meeting.

    Agenda: On March 4, 2016, the committee will meet in open session to discuss and make recommendations on the selection of strains to be included in the influenza virus vaccines for the 2016-2017 influenza season.

    FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting. Background material is available at Scroll down to the appropriate advisory committee meeting link.

    Procedure: Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before February 19, 2016. Oral presentations from the public will be scheduled between approximately 12:40 p.m. and 1:40 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before February 10, 2016. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by February 11, 2016.

    Persons attending FDA's advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets.

    FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with disabilities. If you require accommodations due to a disability, please contact Sujata Vijh at least 7 days in advance of the meeting.

    FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at for procedures on public conduct during advisory committee meetings.

    Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2).

  • National Science Foundation

  • Sunshine Act Meeting; National Science Board

    The National Science Board's Executive Committee, pursuant to NSF regulations (45 CFR part 614), the National Science Foundation Act, as amended (42 U.S.C. 1862n-5), and the Government in the Sunshine Act (5 U.S.C. 552b), hereby gives notice of the scheduling of a teleconference for the transaction of National Science Board business, as follows:

    DATE AND TIME: Friday, January 8, 2016 from 3:00-4:00 p.m. EST.

    SUBJECT MATTER: (1) Chair's opening remarks; and (2) Discussion of agenda for the February 2016 meeting of the National Science Board.

    STATUS: Open

    LOCATION: This meeting will be held by teleconference at the National Science Foundation, 4201 Wilson Blvd., Arlington, VA 22230. A public listening line will be available. Members of the public must contact the Board Office [call 703-292-7000 or send an email message to] at least 24 hours prior to the teleconference for the public listening number.

    UPDATES AND POINT OF CONTACT: Please refer to the National Science Board Web site for additional information. Meeting information and updates (time, place, subject matter or status of meeting) may be found at Point of contact for this meeting is: James Hamos, 4201 Wilson Blvd., Arlington, VA 22230. Telephone: (703) 292-8000.

back to Federal Register Resource

Bookmark and Share

Trending News

Latest Twitter


Subscribe to our newsletter, sent out every month.